rdus stock forecast
rdus stock forecast

Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Less than a week later, an FDA advisory committee voted to recommend approval of Pfizer’s respiratory syncytial virus vaccine in older adults. The FDA’s PDUFA date to make a decision on the RSV vaccine is scheduled for May 2023.

rdus stock forecast

The P/E ratio of Radius Health is -6.90, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Get stock recommendations, portfolio guidance, and more from The Motley Fool’s premium services. Investors appear to be fixated on Pfizer’s COVID-19 headwinds. However, the company predicts brighter days are ahead even on that front.

About Radius Health (NASDAQ:RDUS) Stock

The information provided is for general information purposes only. No information, materials, services and other content provided on this page constitute solicitation, recommendation, endorsement or any financial, investment, or other advice. Seek independent professional consultation in the form of legal, financial, and fiscal advice before making any investment decision. Forecst.com predicts future values using technical analysis of a large number of analytical parameters. RDUS stock returns are also predicted based on historical data.

Radius Health stock traders use a variety of tools to make a prediction on which way the RDUS market is likely to head next. These tools can roughly be divided into indicators and chart patterns. According to our Radius Health stock prediction for 2030, RDUS stock will be priced at $ 68.71 in 2030.

One share of RDUS stock can currently be purchased for approximately $10.08. In the past three months, Radius Health insiders have not sold or bought any company stock. Radius Health does not have a long track record of dividend growth. There is no current short interest data available for RDUS. Radius Health has received no research coverage in the past 90 days. MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

  • All three of the major U.S. stock averages after a consortium of banks led by JPMorgan, Citigroup and Bank of America provided First Republic Bank will $30 billion in deposits.
  • But while I think the conventional wisdom is correct about the challenges that Pfizer faces, the conclusion about the stock is wrong.
  • According to analysts’ consensus price target of $8.67, Radius Health has a forecasted downside of 14.0% from its current price of $10.08.
  • The seller of cookware and home furnishings posted revenue of $2.45 billion in the period, which did not meet Street forecasts.

In the table below you can find two types of moving averages, simple moving average and exponential moving average . Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Radius Health Inc. is a science-driven fully integrated biopharmaceutical company that is committed to developing and commercializing innovative endocrine and other therapeutics. Radius’ lead product, TYMLOS® injection, was approved by the U.S. Food and Drug Administration for the treatment of postmenopausal women with osteoporosis at high risk for fracture.

The company expects new product launches to more than offset the losses from products with patent expirations. It thinks that business development deals will add around $25 billion in new revenue by 2030. As an investor, you want to buy stocks with the highest probability of https://day-trading.info/ success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style. Highlights important summary options statistics to provide a forward looking indication of investors’ sentiment.

As the name suggests, a moving average provides the average closing price for RDUS stock over a selected time frame, which is divided into a number of periods of the same length. For example, a 12-day simple moving average for RDUS is a sum of RDUS’s closing prices over the last 12 days which is then divided by 12. Let’s use a 1-hour candlestick chart as an example of how this type of price chart gives us information about opening and closing prices. The chart is divided into “candles” that give us information about Radius Health’s stock price action in 1-hour chunks.

What is the Radius Health stock prediction for 2030?

The San Francisco-based company said it had net income of $5.28 per share. Earnings, adjusted for asset impairment costs, were $5.50 per share. United States Steel is guiding to first quarter 2023 adjusted EBITDA of approximately $375 million. First quarter 2023 adjusted net earnings per diluted share is expected to be in the range of $0.58 to $0.63. These positive developments seem to be underappreciated by investors. Pfizer has had a string of good news in recent weeks, including several positive regulatory decisions.

rdus stock forecast

This forecast is based on the stock’s average growth over the past 10 years. According to our Radius Health stock prediction for 2025, RDUS stock will be priced at $ 17.44 in 2025. Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Find the latest RDUS analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. For the current quarter ending in April, Five Below said it expects revenue in the range of $723 million to $735 million.

These returns cover a period from January 1, 1988 through February 6, 2023. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations.

Right-click on the chart to open the Interactive Chart menu. For US and Canadian Stocks, the Overview page includes key statistics on the stock’s fundamentals, with a link to see more. Provides a general description of the business conducted japanese broker rakuten securities expands stock offering by this company. Barchart is committed to ensuring digital accessibility for individuals with disabilities. We are continuously working to improve our web experience, and encourage users to Contact Us for feedback and accommodation requests.

The company expects full-year earnings in the range of $11.07 to $11.59 per share, with revenue ranging from $7.67 billion to $7.84 billion. On a per-share basis, the Hamilton, Bermuda-based company said it had net income of $5.02. Earnings, adjusted for non-recurring costs, were $5.52 per share. The company’s shares rose about 8% to $220 in after-market trading. The average estimate of 10 analysts surveyed by Zacks Investment Research was for earnings of $5.41 per share.

At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.52% per year.


Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. 3 equities research analysts have issued 12 month price objectives for Radius Health’s shares.

rdus stock forecast

All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google. We do not allow any sharing of private or personal contact or other information about any individual or organization.

Stocks Mentioned

When making a Radius Health stock forecast, most traders use candlestick charts, as they provide more information than a simple line chart. 1-hour, 4-hour and 1-day candlestick charts are among the most popular. Any opinions, news, research, analyses, prices, or other information offered by AIStockFinder is provided as general market commentary, and does not constitute investment advice.

Its dividend has risen to 4.1%, the highest level since mid-2021. Over the past five weeks, Pfizer has had an impressive string of good news. Food and Drug Administration approved Cibinqo for treating adolescents between the ages of 12 and 18 with atopic dermatitis.

Berkshire paid about $466.68 million for 7.9 million Occidental shares between March 13 and March 15, according to the filing. While the company names will change upon the spin-off, which Kellogg intends to complete by the end of this year, the «Kellogg’s» brand will remain on the packaging of both companies’ products around the world. «Inflation is projected to remain too high for too long,» ECB President Christine Lagarde told a news conference, reading from the statement agreed by the bank’s policymakers. MARKETS ECB backs rate hike despite banking sector chaos The European Central Bank announced another big spike in interest rates as the global banking sector reels from SVB, Credit Suisse and potential bank collapses. “The government took decisive and forceful actions to strengthen public confidence” in the U.S. banking system, Yellen said in testimony before the committee.

Analysts surveyed by Zacks had expected revenue of $634.1 million. The discount retailer posted revenue of $1.12 billion in the period, also surpassing Street forecasts. Five Below Inc. on Wednesday reported fiscal fourth-quarter profit of $171.3 million. Signet Jewelers Ltd. on Thursday reported profit of $277.3 million in its fiscal fourth quarter. Real-time analyst ratings, insider transactions, earnings data, and more.

Same-store sales for the company climbed 5.7% in the fourth quarter ended Feb. 3, but missed analysts’ average estimate of a 6% increase, according to Refinitiv data, due to inventory damages caused by winter storm Elliott. The seller of cookware and home furnishings posted revenue of $2.45 billion in the period, which did not meet Street forecasts. Pfizer stock currently trades at only 12 times expected earnings.